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Critically Appraised Paper
NSAIDs reduce osteoarthritic knee pain in the short term;
long term effects are unknown
Synopsis
Commentary
Summary of Bjordal JM, Ljunggren AE, Klovning A and
Slørdal L (2004): Non-steroidal anti-inflammatory drugs,
including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee
pain: Meta-analysis of randomised placebo controlled trials.
BMJ 329: 1317–1323. (Prepared by Gro Jamtvedt,
Norwegian Health Services Research Centre and Kåre Birger
Hagen, National Resource Centre in Rheumatology, Oslo,
Norway.)
Question What is the analgesic effect of NSAIDs, including
coxibs, in patients with knee osteoarthritis? Data Sources
MEDLINE, EMBASE, and The Cochrane Controlled Trials
Register (CENTRAL) from 1966 to April 2004. Reference
lists from relevant articles were scanned. Relevant studies
were also traced by contacting experts. Study selection
Randomised controlled trials of patients whose knee
osteoarthritis had been verified by clinical examination
according to the American College of Rheumatology criteria
and by X-ray, where the intervention groups had to have
received matched placebo drug or adequate NSAID dose and
the outcome measure was pain. Data extraction
Methodological quality was assessed according to predefined
criteria (Jadad scale). It is not reported if selection and
assessment of trials were done by one or more reviewers.
Results Twenty-three trials of moderate or good
methodological quality were included. The included patients
(n = 10 845) had a median age of 62.5 years, 67.9% were
women, and the median duration of symptoms was 8.2 years.
Thirteen trials used an additional inclusion criterion by
requiring a predefined minimum flare of symptoms when
NSAID treatment was discontinued in the pretreatment wash
out period. Only one trial reported long term effects on pain
but found no significant difference between NSAID and
placebo at one, two, three, and four years after start of
treatment. For short term effects (2–13 weeks) the pooled
effect size in change in pain between the treatment and the
placebo groups was 0.32 (95% CI 0.24 to 0.39), comparable
to 10.1 mm on visual analogue scale (VAS) (7.4 to 12.8) or
15.6% better than placebo. For the subgroup of 10 trials (n =
4565) that did not require patients to have a minimum flare of
symptoms after treatment with NSAIDs was stopped before
the trial, the pooled effect size for pain was 0.23 (0.16 to 0.31)
or 5.9 mm on VAS (3.8 to 7.9). Conclusion NSAIDs can
reduce short term pain in osteoarthritis of the knee slightly
better than placebo. Evidence of long term effects from oral
NSAIDs is still lacking.
Osteoarthritis (OA) is the most common cause of
musculoskeletal disability and pain, and the prevalence is
increasing with the increasing age of population. Painful
joints often lead to a downward spiral of inactivity, muscle
dysfunction and weight gain, increased disability and reduced
participation in life activities. According to the EULAR
recommendations (Jordan et al 2003), current treatment for
knee OA includes non-pharmacological treatments (for
example exercise and education), and pharmacological
treatments (paracetamol, NSAIDs, and topical treatments).
How is the current evidence to support these treatment
alternatives?
The present high quality review showed that NSAIDs may
have a small to moderate short-term effect on pain whereas
long-term use of NSAIDs is not supported. For short-term
effects (2–13 weeks) the pooled effect size in change in pain
between the treatment and the placebo groups was moderate
(0.32). For the subgroup of 10 trials that did not require
patients to have a minimum flare of symptoms after treatment
with NSAIDs was stopped before the trial, the pooled effect
size for pain was small (0.23).
Recent high quality trials, systematic reviews and reports
have concluded that therapeutic exercises are beneficial for
patients with knee OA (Jordan et al 2003, Roddy et al 2005,
Fransen et al 2002, Nasjonalt kunnskapssenter for
helsetjenesten 2004). The Roddy et al (2005) review
concluded that strengthening and aerobic exercise had
moderate effects on pain (effect size range 0.44 to 0.70) and
function (effect size range 0.37 to 0.76).
According to current evidence, therapeutic exercises are of
benefit for patients with knee OA, and NSAIDs may give
short-term pain reduction. The combination of these two
interventions might be beneficial, administered as long-term,
guided exercise programs, supplemented with short term use
of NSAIDs to allow patients to start training or overcome
painful periods.
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